Sign in Subscribe

oncolens

oncolens

Atlanta startup OncoLens closes $7.25 M Series A round in its battle against cancer

Atlanta startup OncoLens closes $7.25 M Series A round in its battle against cancer

OncoLens, an Atlanta-based digital health IT company, is streamlining cancer care with its innovative treatment planning platform. The platform enables data integration and collaboration among specialists, thereby reducing overall costs and shortening timelines for treatment planning. “Unlike many other healthcare applications whose core users are either administrative or single-

Oncolens

#NewNormal: How COVID-19 Changed Healthcare And Brought Telemedicine To The Forefront

Put simply, says Dr. Angela Fusaro, the COVID-19 pandemic has changed how people interact with one another. Healthcare is no exception. “From a provider perspective, I’ve seen doctors who didn’t previously offer telehealth services scrambling to implement the technology in some way,” says Fusaro, an emergency room

Oncolens

OncoLens Raises $2.5M in Pre-Series A Funding Round Led by BIP Capital

OncoLens, an Atlanta-based SaaS platform dedicated to streamlining the planning of cancer treatment, has announced the closing of a $2.5M pre-Series A funding round led by BIP Capital. Atlanta Technology Angels and the Robbins Fund also participated in the round; all three had previously invested in OncoLens’

Oncolens

OncoLens Raises Seed Funding to Streamline Cancer Treatment Planning

OncoLens, a clinical decision software that focuses on oncology (cancer care), has closed a $1.35 million seed round led by BIP Capital and Atlanta Technology Angels (ATA). OncoLens was founded by CEO Anju Mathew, formerly head of technology and innovation at McKesson’s Medical Surgical business unit, and Chief

Ask AI for this week’s Hypepotamus briefing